Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether a zinc-free insulin is an effective
treatment option for lipoatrophy in patients with type 1 Diabetes (T1D) and insulin pump
(CSII, continuous subcutaneous insulin infusion) therapy.